Mark A. Lemmon
Impact in
- Cell Biology top 0.02%
- Cellular transport and secretion
- Molecular Biology top 0.1%
- Protein Kinase Regulation and GTPase Signaling
- Lipid Membrane Structure and Behavior
- Glycosylation and Glycoproteins Research
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 37
- Glycosylation and Glycoproteins Research 19
- Lipid Membrane Structure and Behavior 16
- PI3K/AKT/mTOR signaling in cancer 12
- Oncology 53
- HER2/EGFR in Cancer Research 43
- Co-authors
- Joseph Schlessinger (28 shared papers)Kathryn M. Ferguson (25 shared papers)Donald M. Engelman (11 shared papers)Jeannine M. Mendrola (10 shared papers)Irit Lax (7 shared papers)Mitchell B. Berger (4 shared papers)Paul B. Sigler (3 shared papers)Daryl E. Klein (11 shared papers)
- Journals
- Journal of Biological Chemistry (19 papers)Proceedings of the National Academy of Sciences (12 papers)Cell (11 papers)Biochemical Journal (10 papers)Molecular Cell (7 papers)
- Partner nations
- United StatesUnited KingdomRussia
In The Last Decade
Mark A. Lemmon
160 papers receiving 26.0k citations
Mark A. Lemmon's Hit Papers
Peers
Comparison fields: 5 of 153
- Cell Biology 7.2k
- Molecular Biology 18.5k
- Oncology 5.7k
- Immunology and Allergy 1.2k
- Radiology, Nuclear Medicine and Imaging 3.3k
Countries citing papers authored by Mark A. Lemmon
This map shows the geographic impact of Mark A. Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lemmon more than expected).
Fields of papers citing papers by Mark A. Lemmon
This network shows the impact of papers produced by Mark A. Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lemmon. The network helps show where Mark A. Lemmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Lemmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cell Signaling by Receptor Tyrosine Kinases Hit paper breakdown → | 2010 | 4935 |
| 2 | Membrane recognition by phospholipid-binding domains Hit paper breakdown → | 2008 | 1211 |
| 3 | An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors Hit paper breakdown → | 2003 | 707 |
| 4 | EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization Hit paper breakdown → | 2003 | 621 |
| 5 | Signal-dependent membrane targeting by pleckstrin homology (PH) domains Hit paper breakdown → | 2000 | 600 |
| 6 | Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Hit paper breakdown → | 1994 | 597 |
| 7 | Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain Hit paper breakdown → | 1995 | 525 |
| 8 | 1995 | 493 | |
| 9 | 2003 | 483 | |
| 10 | 1992 | 459 | |
| 11 | 1992 | 433 | |
| 12 | 1996 | 428 | |
| 13 | 1995 | 428 | |
| 14 | 1994 | 416 | |
| 15 | 1998 | 386 | |
| 16 | 2010 | 386 | |
| 17 | The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases Hit paper breakdown → | 2014 | 360 |
| 18 | 2012 | 310 | |
| 19 | 1997 | 306 | |
| 20 | 2004 | 296 |
About Mark A. Lemmon
Mark A. Lemmon is a scholar working on Molecular Biology, Oncology, Cell Biology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 164 papers that have together received 26.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (43 papers), Cellular transport and secretion (41 papers), Protein Kinase Regulation and GTPase Signaling (37 papers), Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (19 papers), Cell Adhesion Molecules Research (18 papers), Lipid Membrane Structure and Behavior (16 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). The work is most often cited by research in Cell Biology (7.2k citations), Molecular Biology (18.5k citations), Oncology (5.7k citations), Immunology and Allergy (1.2k citations) and Radiology, Nuclear Medicine and Imaging (3.3k citations). Mark A. Lemmon has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Joseph Schlessinger, Kathryn M. Ferguson, Donald M. Engelman, Jeannine M. Mendrola, Irit Lax, Mitchell B. Berger, Paul B. Sigler, Daryl E. Klein, Daniel J. Leahy and Ravi Radhakrishnan. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Cell, Biochemical Journal and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.